{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:47:53Z","timestamp":1787795273799,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,11]]},"DOI":"10.7759\/cureus.77282","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:28:59Z","timestamp":1736612939000},"source":"Crossref","is-referenced-by-count":1,"title":["Effect of Suprachoroidal Triamcinolone Acetonide on Intraocular Pressure in Macular Edema: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Ali","family":"Nauman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishal","family":"Seyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(98)96025-0","article-title":"The 14-year incidence of visual loss in a diabetic population","volume":"105","author":"Moss SE","year":"1998","unstructured":"Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998, 105:998-1003. 10.1016\/s0161-6420(98)96025-0","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"Daruich A","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, et al.. Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res. 2018, 63:20-68. 10.1016\/j.preteyeres.2017.10.006","journal-title":"Prog Retin Eye Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa SA","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, Abdelkader H. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021, 11:866-93. 10.1007\/s13346-020-00843-z","journal-title":"Drug Deliv Transl Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","author":"Diabetic Retinopathy Clinical Research Network","year":"2008","unstructured":"Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008, 115:1447-9. 10.1016\/j.ophtha.2008.06.015","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.10.005","article-title":"A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: the European DME registry study","volume":"127","author":"Rosenblatt A","year":"2020","unstructured":"Rosenblatt A, Udaondo P, Cunha-Vaz J, et al.. A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: the European DME registry study. Ophthalmology. 2020, 127:377-93. 10.1016\/j.ophtha.2019.10.005","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0010-x","article-title":"Fluocinolone acetonide intravitreal implant (Iluvien\u00ae): in diabetic macular oedema","volume":"73","author":"Sanford M","year":"2013","unstructured":"Sanford M. Fluocinolone acetonide intravitreal implant (Iluvien\u00ae): in diabetic macular oedema. Drugs. 2013, 73:187-93. 10.1007\/s40265-013-0010-x","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5","volume":"127","author":"Ip MS","year":"2009","unstructured":"Ip MS, Scott IU, VanVeldhuisen PC, et al.. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009, 127:1101-14. 10.1001\/archophthalmol.2009.234","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.233","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6","volume":"127","author":"Scott IU","year":"2009","unstructured":"Scott IU, Ip MS, VanVeldhuisen PC, et al.. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009, 127:1115-28. 10.1001\/archophthalmol.2009.233","journal-title":"Arch Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone Implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne JE","year":"2019","unstructured":"Thorne JE, Sugar EA, Holbrook JT, et al.. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone Implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019, 126:283-95. 10.1016\/j.ophtha.2018.08.021","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen QD","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, et al.. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012, 119:789-801. 10.1016\/j.ophtha.2011.12.039","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/11206900-000000000-00000","article-title":"Ranibizumab: in macular oedema following retinal vein occlusion","volume":"71","author":"Garnock-Jones KP","year":"2011","unstructured":"Garnock-Jones KP. Ranibizumab: in macular oedema following retinal vein occlusion. Drugs. 2011, 71:455-63. 10.2165\/11206900-000000000-00000","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000315158","article-title":"Differentiating intraocular glucocorticoids","volume":"224","author":"Edelman JL","year":"2010","unstructured":"Edelman JL. Differentiating intraocular glucocorticoids. Ophthalmologica. 2010, 224:25-30. 10.1159\/000315158","journal-title":"Ophthalmologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan MC","year":"2000","unstructured":"Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000, 11:478-83. 10.1097\/00055735-200012000-00016","journal-title":"Curr Opin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen LM","year":"2004","unstructured":"Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004, 138:740-3. 10.1016\/j.ajo.2004.06.067","journal-title":"Am J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel SR","year":"2011","unstructured":"Patel SR, Lin AS, Edelhauser HF, Prausnitz MR. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res. 2011, 28:166-76. 10.1007\/s11095-010-0271-y","journal-title":"Pharm Res"},{"key":"ref16","article-title":"Hydrostatic pressure of the suprachoroidal space","volume":"30","author":"Emi K","year":"1989","unstructured":"Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989, 30:233-8.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2018.03.008","article-title":"Suprachoroidal triamcinolone acetonide for diabetic macular edema: the Hulk trial","volume":"2","author":"Wykoff CC","year":"2018","unstructured":"Wykoff CC, Khurana RN, Lampen SI, Noronha G, Brown DM, Ou WC, Sadda SR. Suprachoroidal triamcinolone acetonide for diabetic macular edema: the Hulk trial. Ophthalmol Retina. 2018, 2:874-7. 10.1016\/j.oret.2018.03.008","journal-title":"Ophthalmol Retina"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.08.007","article-title":"Suprachoroidal  CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study","volume":"5","author":"Barakat MR","year":"2021","unstructured":"Barakat MR, Wykoff CC, Gonzalez V, Hu A, Marcus D, Zavaleta E, Ciulla TA. Suprachoroidal  CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study. Ophthalmol Retina. 2021, 5:60-70. 10.1016\/j.oret.2020.08.007","journal-title":"Ophthalmol Retina"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.36.2.1194","article-title":"Efficacy and safety of suprachoroidal triamcinolone acetonide in cases of resistant diabetic macular edema","volume":"36","author":"Tayyab H","year":"2020","unstructured":"Tayyab H, Ahmed CN, Sadiq MA. Efficacy and safety of suprachoroidal triamcinolone acetonide in cases of resistant diabetic macular edema. Pak J Med Sci. 2020, 36:42-7. 10.12669\/pjms.36.2.1194","journal-title":"Pak J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the Tanzanite study","volume":"2","author":"Campochiaro PA","year":"2018","unstructured":"Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D, Noronha G. Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the Tanzanite study. Ophthalmol Retina. 2018, 2:320-8. 10.1016\/j.oret.2017.07.013","journal-title":"Ophthalmol Retina"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318019","article-title":"Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)","volume":"106","author":"Henry CR","year":"2022","unstructured":"Henry CR, Shah M, Barakat MR, et al.. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2022, 106:802-6. 10.1136\/bjophthalmol-2020-318019","journal-title":"Br J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh S","year":"2020","unstructured":"Yeh S, Khurana RN, Shah M, et al.. Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial. Ophthalmology. 2020, 127:948-55. 10.1016\/j.ophtha.2020.01.006","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1464_20","article-title":"Modified inexpensive needle for suprachoroidal triamcinolone acetonide injections in pseudophakic cystoid macular edema","volume":"69","author":"Oli A","year":"2021","unstructured":"Oli A, Waikar S. Modified inexpensive needle for suprachoroidal triamcinolone acetonide injections in pseudophakic cystoid macular edema. Indian J Ophthalmol. 2021, 69:765-7. 10.4103\/ijo.IJO_1464_20","journal-title":"Indian J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328783-effect-of-suprachoroidal-triamcinolone-acetonide-on-intraocular-pressure-in-macular-edema-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:29:01Z","timestamp":1736612941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328783-effect-of-suprachoroidal-triamcinolone-acetonide-on-intraocular-pressure-in-macular-edema-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.77282","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}